Reach Out 2: Randomized Clinical Trial of Emergency Department-Initiated Hypertension Mobile Health Intervention Connecting Multiple HealthSystems
伸出援手 2:急诊室发起的高血压移动健康干预连接多个卫生系统的随机临床试验
基本信息
- 批准号:10791418
- 负责人:
- 金额:$ 59.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-24 至 2028-11-30
- 项目状态:未结题
- 来源:
- 关键词:Accident and Emergency departmentAddressAmericanAntihypertensive AgentsAppointmentAppointments and SchedulesBlack AmericanBlack raceBlindedBlood PressureBlood Pressure MonitorsCardiovascular DiseasesCardiovascular systemCaringChronic DiseaseControl GroupsDataDementiaDiagnosisDiastolic blood pressureEligibility DeterminationEmergency Department patientEmergency department visitEnrollmentEpidemicEthnic PopulationEvidence based interventionFederally Qualified Health CenterFeedbackFrequenciesGoalsGuidelinesHealthcare SystemsHigh PrevalenceHomeHome Blood Pressure MonitoringHypertensionIndividualInequityInstitutionInstructionInterventionLow incomeMyocardial InfarctionParticipantPatient RecruitmentsPatientsPersonsPharmaceutical PreparationsPopulationPrimary CareRandomizedStrokeTestingTransportationUnderserved PopulationUnemploymentWorkarmblood pressure controlblood pressure reductioncardiovascular risk factordisease disparityfallsfollow-uphealth equityhypertension controlhypertensiveintervention participantsmHealthmedically underserved populationmiddle agemodels and simulationmodifiable riskmortalitynovel strategiesprimary care providerprimary care visitracial populationrandomized, clinical trialssafety netsimulationstandard of caretreatment armtreatment as usualtreatment duration
项目摘要
Hypertension is the most important modifiable risk factor for cardiovascular disease. Black Americans have the
highest prevalence of hypertension and the lowest rates of blood pressure (BP) control of any racial or ethnic
group in the U.S., contributing to cardiovascular disease disparities. Low-income Americans are also
disproportionally burdened by hypertension. To achieve health equity, new approaches to hypertension
management leveraging safety-net healthcare systems to reach underserved populations are needed.
One approach to addressing the hypertension epidemic is to identify and treat people undiagnosed, untreated,
or with undertreated hypertension - people who have fallen through the cracks in the healthcare system. We
did this in Reach Out 1 (R01MD011516), a mobile health (mHealth) 8-arm factorial trial of hypertensive
patients recruited from a safety-net ED. Among the ~500 majority Black, mid-life participants, 43% were
unemployed; 21% did not carry a diagnosis of hypertension; 51% were not taking antihypertensive
medications, and 22% did not have a primary care provider. Overall, systolic BP declined by 9.2 mmHg (95%
CI -12.2 to - 6.3) after 6 months, without differences across treatment arms. Reach Out 1 successfully enrolled
a hypertensive, medically underserved population into a mHealth intervention. Despite a very large reduction in
BP overall, the efficacy of the Reach Out mHealth intervention is uncertain, given the lack of a control group.
Reach Out 2 proposes to test the most promising components of Reach Out 1 in a randomized open, blinded-
endpoint (PROBE) controlled trial. Reach Out 2, continues our work with the same safety-net ED and Federally
Qualified Health Centers. In Reach Out 2, we will compare usual care, to 6-months of prompted self-monitored
blood pressure (SMBP) monitoring with tailored feedback and facilitated primary care appointment and
transportation. The usual care group will receive instructions to follow up with a primary care provider after ED
discharge. After 6 months, the intervention participants will enter an extended treatment period of long-term
SMBP monitoring. To contextualize our findings, we will use our chronic disease agent-based simulation model
to estimate the reduction in myocardial infarction, stroke, and dementia if Reach Out 2 were to be implemented
in safety-net EDs across the US. The overarching goal of our proposal is to determine whether a low-tech
mHealth intervention will reduce BP more than usual care among patients recruited from a safety-net ED and
to understand the potential national impact of such an intervention. Because safety-net EDs are anchor
institutions that care for large populations of medically underserved hypertensive people, mHealth strategies
initiated here have tremendous potential to reduce cardiovascular inequities. To reach this potential, evidence-
based interventions to reduce BP must be identified (aim 1), long-term engagement evaluated (aim 2), and
their impact understood (aim 3).
高血压是心血管疾病最重要的可改变危险因素。美国黑人有
任何种族或民族中高血压患病率最高且血压 (BP) 控制率最低
美国的一个群体,导致心血管疾病的差异。低收入美国人也
高血压负担过重。为了实现健康公平,高血压的新方法
管理层需要利用安全网医疗保健系统来覆盖服务不足的人群。
解决高血压流行问题的一种方法是识别和治疗未经诊断、未经治疗、
或高血压治疗不足的人——那些在医疗保健系统中被忽视的人。我们
在 Reach Out 1 (R01MD011516) 中做到了这一点,这是一项针对高血压的移动健康 (mHealth) 8 臂析因试验
从安全网急诊室招募的患者。在大约 500 名中年黑人参与者中,43% 是
失业; 21% 没有诊断出高血压; 51% 没有服用抗高血压药物
药物治疗,22% 的人没有初级保健提供者。总体而言,收缩压下降了 9.2 mmHg(95%
6 个月后 CI -12.2 至 - 6.3),治疗组之间没有差异。伸出援手 1 已成功注册
高血压、医疗服务不足的人群接受移动医疗干预。尽管大幅减少
总体而言,由于缺乏对照组,BP 的 Reach Out mHealth 干预措施的效果尚不确定。
Reach Out 2 提议在随机、开放、盲法中测试 Reach Out 1 中最有前途的组件。
终点(PROBE)对照试验。伸出援手 2,继续我们的工作与相同的安全网 ED 和联邦
合格的健康中心。在《Reach Out 2》中,我们将比较常规护理和 6 个月的提示自我监控
血压 (SMBP) 监测,提供定制反馈并促进初级保健预约和
运输。常规护理组将收到 ED 后与初级保健提供者进行跟进的指示
释放。 6个月后,干预参与者将进入长期延长治疗期
SMBP 监测。为了将我们的发现结合起来,我们将使用基于慢性疾病代理的模拟模型
估计实施“Reach Out 2”后心肌梗塞、中风和痴呆症的减少情况
在美国各地的安全网急诊室。我们提案的总体目标是确定低技术含量是否
对于从安全网急诊室招募的患者,移动健康干预将比常规护理更能降低血压
了解此类干预措施对国家的潜在影响。因为安全网 ED 是锚
照顾大量医疗服务不足的高血压患者的机构、移动医疗战略
这里发起的行动具有减少心血管不平等的巨大潜力。为了发挥这一潜力,证据-
必须确定降低血压的干预措施(目标 1),评估长期参与(目标 2),以及
他们的影响得到了理解(目标 3)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Joseph Meurer其他文献
William Joseph Meurer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Joseph Meurer', 18)}}的其他基金
Reach Out: Randomized Clinical Trial of Emergency Department-Initiated Hypertension Behavioral Intervention Connecting Multiple Health Systems
伸出援手:急诊室发起的连接多个卫生系统的高血压行为干预的随机临床试验
- 批准号:
10121491 - 财政年份:2017
- 资助金额:
$ 59.93万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
NIDA Clinical Trials Network: New York Node
NIDA 临床试验网络:纽约节点
- 批准号:
10855627 - 财政年份:2023
- 资助金额:
$ 59.93万 - 项目类别:
Development of a digital therapeutic targeting anxiety sensitivity to reduce PTSD-SUD in women presenting for emergency care after sexual assault.
开发一种针对焦虑敏感性的数字疗法,以减少性侵犯后寻求紧急护理的女性的 PTSD-SUD。
- 批准号:
10449766 - 财政年份:2023
- 资助金额:
$ 59.93万 - 项目类别:
Michigan Emergency Department Improvement Collaborative AltERnaTives to admission for Pulmonary Embolism (MEDIC ALERT PE) Study
密歇根急诊科改进合作入院肺栓塞 (MEDIC ALERT PE) 研究
- 批准号:
10584217 - 财政年份:2023
- 资助金额:
$ 59.93万 - 项目类别:
Integrating the Youth Nominated Support Team (YST) with CBT for Black Youth with Acute Suicide Risk
将青年提名支持团队 (YST) 与针对有急性自杀风险的黑人青年的 CBT 相结合
- 批准号:
10573542 - 财政年份:2023
- 资助金额:
$ 59.93万 - 项目类别:
Emergency Department-Initiated Medications for Alcohol Use Disorder
急诊科启动的酒精使用障碍药物
- 批准号:
10567250 - 财政年份:2023
- 资助金额:
$ 59.93万 - 项目类别: